Author:
Jiann B-P,Yu C-C,Su C-C,Tsai J-Y
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Wysowski DK, Swann J . Use of medications for erectile dysfunction in the United States, 1996 through 2001. J Urol 2003; 169: 1040–1042.
2. Jiann BP, Yu CC, Su CC . Impact of introduction of sildenafil on other treatment modalities for erectile dysfunction: a study of nationwide and local hospital sale. Int J Impot Res 2004; 16: 527–530.
3. Jiann BP, Yu CC, Tsai JY, Wu TT, Lee YH, Huang JK . What to learn about sildenafil in the treatment of erectile dysfunction from 3-year clinical experience. Int J Impot Res 2003; 15: 412–417.
4. Hackett GI, Milledge A . A 12-month follow up of 260 patients taking sildenafil. NHS clinical experience. In: Fourth Congress of the European Society for Sexual and Impotence Research (ESSIR) 2001, 30 September–3 October 2001 (poster 171).
5. Casabe A, Cobreros C, Bechara A, Roletto L, Cheliz G, Hochman S et al. Drop out reason in responders to sildenafil. Int J Impot Res 2001; 13(Suppl 2): S5, (moderated poster 9).
Cited by
71 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献